Search Results 1911-1920 of 13397 for monoclonal antibody

  1. Satralizumab-mwge (subcutaneous route) - Side effects & dosage - Mayo Clinic

    It is used in patients who are anti-aquaporin-4 (AQP4) antibody positive. This medicine is to be given only by or under the direct supervision of your ...

  2. Melanoma Relatlimab Nivolumab - Mayo Clinic

    ... antibody (except if given as adjuvant or neoadjuvant therapy for melanoma), or any other antibody or drug specifically targeting T-cell costimulation or ...

  3. Publications - Dong Chen, M.D., Ph.D. - Mayo Clinic

    ... antibody levels. Int J Lab Hematol. 2024 Aug; 46 (4):695-704 Epub 2024 Feb ... antibodies. Blood. 2022 Dec 22; 140 (25):2722-2729. View PubMed; Tefferi A ...

  4. A Study Of Taxane, Trastuzumab, And Pertuzumab With Or Without Atezolizumab In Treating Metastatic Breast Cancer Patients - Mayo Clinic

    ... antibody (HBcAb) test at screening, are eligible for the study if active HBV infection is ruled out on the basis of HBV deoxyribonucleic acid (DNA) viral ...

  5. Hematology - Clinical trials

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  6. Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

    Serum monoclonal protein >= 1.0 g/dL; >= 200 mg of monoclonal protein in the urine on 24 hour electrophoresis; Serum immunoglobulin free light chain >=10 mg ...

  7. A Study To Evaluate Induction Chemotherapy With ABVD Followed By Brentuximab Vedotin Consolidation In Previously-untreated, Non-bulky Stage I Or II Hodgkin Lymphoma - Mayo Clinic

    For this research study, the use of brentuximab vedotin in newly diagnosed Hodgkin lymphoma is considered investigational. Brentuximab vedotin is an antibody ...

  8. A Study Of The Safety And Efficacy Of Atezolizumab Administered In Combination With Bevacizumab And/or Other Treatments In Participants With Solid Tumors - Mayo Clinic

    Documented virology status of hepatitis, as confirmed by screening hepatitis B surface antigen (HBsAg), antibody to hepatitis B core antigen (anti-HBc), and ...

  9. Safety And Efficacy Of Bb2121 (Ide-cel) Combinations In Multiple Myeloma - Mayo Clinic

    Arm A Cohort 1 and Arm B: Subject has received prior treatment with an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody-containing ...

  10. Study To Evaluate The Efficacy And Safety Of Elafibranor In Patients With Primary Biliary Cholangitis (PBC) And Inadequate Response To Ursodeoxycholic Acid - Mayo Clinic

    ... antibody; interface hepatitis), and PBC (ALP ≥2x ULN; AMA, and non ... 12 months prior to inclusion visit and throughout the trial (up to last study visit): ...